Management of Cardiovascular Risk Factors
1 other identifier
observational
1,492
1 country
36
Brief Summary
This practical experience should report a retrospective collection of data regarding cardiovascular risk factors of cardiovascular diseases. The goal is an evaluation of the development of the risk profile of cardiovascular patients with simultaneous treatment of hypertension and hyperlipidemia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2009
Shorter than P25 for all trials
36 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 19, 2009
CompletedFirst Posted
Study publicly available on registry
February 20, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedNovember 16, 2010
November 1, 2010
10 months
February 19, 2009
November 15, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The goal is an evaluation of the development of the risk profile of cardiovascular patients with simultaneous treatment of hypertension and hyperlipidemia.
Inclusion visit, 6 to 9 months before inclusion visit and / or 12 to 15 months before inclusion visit
Study Arms (1)
1
Patients with hypertension and hyperlipidemia and other CV risk factors
Eligibility Criteria
Patients with hypertension and hyperlipidemia and other CV risk factors
You may qualify if:
- Patients received a anti-hypertension treatment in addition to cholesterol lowering treatment during the observation period
- Patients received a cholesterol lowering treatment in addition to hypertension treatment during the observation period
- Patients received during the observation time new cholesterol lowering and hypertension treatment
You may not qualify if:
- Patients received during the observation time only cholesterol lowering or only anti-hypertension treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (36)
Research Site
Frick, Canton of Aargau, Switzerland
Research Site
Neuenhof, Canton of Aargau, Switzerland
Research Site
Riehen, Canton of Basel-City, Switzerland
Research Site
Thun, Canton of Bern, Switzerland
Research Site
Wynigen, Canton of Bern, Switzerland
Research Site
Geneva, Canton of Geneva, Switzerland
Research Site
Le Lignon, Canton of Geneva, Switzerland
Research Site
Meyrin, Canton of Geneva, Switzerland
Research Site
Schwyz, Canton of Schwyz, Switzerland
Research Site
Gerlafingen, Canton of Solothurn, Switzerland
Research Site
Lohn SO, Canton of Solothurn, Switzerland
Research Site
Zuchwil, Canton of Solothurn, Switzerland
Research Site
Rorschach, Canton of St. Gallen, Switzerland
Research Site
Sankt Gallen, Canton of St. Gallen, Switzerland
Research Site
Bassins, Canton of Vaud, Switzerland
Research Site
Gland, Canton of Vaud, Switzerland
Research Site
Lausanne, Canton of Vaud, Switzerland
Research Site
Montreux, Canton of Vaud, Switzerland
Research Site
Nyon, Canton of Vaud, Switzerland
Research Site
Zug, Canton of Zug, Switzerland
Research Site
Affoltern am Albis, Canton of Zurich, Switzerland
Research Site
Feldmeilen, Canton of Zurich, Switzerland
Research Site
Herrliberg, Canton of Zurich, Switzerland
Research Site
Langnau am Albis, Canton of Zurich, Switzerland
Research Site
Richterswil, Canton of Zurich, Switzerland
Research Site
Rüti, Canton of Zurich, Switzerland
Research Site
Zurich, Canton of Zurich, Switzerland
Research Site
Arbedo, Canton Ticino, Switzerland
Research Site
Bellinzona, Canton Ticino, Switzerland
Research Site
Claro, Canton Ticino, Switzerland
Research Site
Coldrerio, Canton Ticino, Switzerland
Research Site
Locarno, Canton Ticino, Switzerland
Research Site
Lugano, Canton Ticino, Switzerland
Research Site
Muralto, Canton Ticino, Switzerland
Research Site
Andeer, Kanton Graubünden, Switzerland
Research Site
Ilanz, Kanton Graubünden, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
February 19, 2009
First Posted
February 20, 2009
Study Start
February 1, 2009
Primary Completion
December 1, 2009
Study Completion
December 1, 2009
Last Updated
November 16, 2010
Record last verified: 2010-11